Meeting NewsVideo

VIDEO: Abicipar yields positive results for long-term wet AMD treatment

CHICAGO ― At the American Academy of Ophthalmology meeting here, Rahul N. Khurana, MD, discusses results from the phase 3 study of abicipar for the treatment of wet age-related macular degeneration. 

CHICAGO ― At the American Academy of Ophthalmology meeting here, Rahul N. Khurana, MD, discusses results from the phase 3 study of abicipar for the treatment of wet age-related macular degeneration. 

    See more from American Academy of Ophthalmology Meeting